Routine intravascular ultrasound guidance of percutaneous coronary intervention: A critical reappraisal

Journal of the American College of Cardiology

Volumn 43, Issue 8, 2004, Pages 1335-1342

  Orford, James L ^a   Lerman, Amir ^a   Holmes, David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

DES; Drug eluting stent(s); FFR; Fractional flow reserve; Intravascular ultrasound; IVUS; MI; Minimum lumen diameter; MLD; Myocardial infarction; PCI; Percutaneous coronary intervention; Target lumen revascularization; Target vessel revascularization; TLR; TVR

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTERY DISSECTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY STENT; DEATH; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SAFETY; SAPHENOUS VEIN GRAFT; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; HUMANS; RANDOMIZED CONTROLLED TRIALS; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 1942517015     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.035     Document Type: Review

References (59)

1. Topol E.J., Nissen S.E. Our preoccupation with coronary luminology The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 92:1995;2333-2342.
2. Tobis J.M., Mallery J.A., Gessert J., et al. Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. Circulation. 80:1989;873-882.
3. Tobis J.M., Mallery J.A., Mahon D., et al. Intravascular ultrasound imaging of human coronary arteries in vivo Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation. 83:1991;913-926.
4. Potkin B.N., Keren G., Mintz G.S., et al. Arterial responses to balloon coronary angioplasty An intravascular ultrasound study. J Am Coll Cardiol. 20:1992;942-951.
5. Jain S.P., Jain A., Collins T.J., Ramee S.R., White C.J. Predictors of restenosis A morphometric and quantitative evaluation by intravascular ultrasound. Am Heart J. 128:1994;664-673.
6. Suarez de Lezo J., Romero M., Medina A., et al. Intracoronary ultrasound assessment of directional coronary atherectomy Immediate and follow-up findings. J Am Coll Cardiol. 21:1993;298-307.
7. Mintz G.S., Potkin B.N., Keren G., et al. Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease. Circulation. 86:1992;1383-1393.
8. Laskey W.K., Brady S.T., Kussmaul W.G., et al. Intravascular ultrasonographic assessment of the results of coronary artery stenting. Am Heart J. 125:1993;1576-1583.
9. Benestent Study Group, Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
10. Stent Restenosis Study Investigators, Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
11. Colombo A., Hall P., Nakamura S., et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 91:1995;1676-1688.
12. Goods C.M., Al-Shaibi K.F., Yadav S.S., et al. Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation. 93:1996;1803-1808.
13. Karrillon G.J., Morice M.C., Benveniste E., et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy 30-day clinical outcome of the French multicenter registry. Circulation. 94:1996;1519-1527.
14. Mintz G.S., Popma J.J., Hong M.K., et al. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol. 78:1996;18-22.
15. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis A serial intravascular ultrasound study. Circulation. 94:1996;1247-1254.
16. Waksman R. Drug-eluting stents From bench to bed. Cardiovasc Radiat Med. 3:2002;226-241.
17. Frey A.W., Hodgson J.M., Muller C., Bestehorn H.P., Roskamm H. Ultrasound-guided strategy for provisional stenting with focal balloon combination catheter. Circulation. 102:2000;2497-2502.
18. Schiele F., Meneveau N., Gilard M., et al. Intravascular ultrasound-guided balloon angioplasty compared with stent Immediate and 6-month results of the multicenter, randomized Balloon Equivalent to Stent (best) study. Circulation. 107:2003;545-551.
19. Laskey W.K., Williams D.O., Vlachos H.A., et al. Changes in the practice of percutaneous coronary intervention A comparison of enrollment waves in the National Heart, Lung, and Blood Institute (nhlbi) dynamic registry. Am J Cardiol. 87:2001;964-969.
20. Blasini R., Neumann F.J., Schmitt C., Bokenkamp J., Schomig A. Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement Impact of dilation pressures. Cathet Cardiovasc Diagn. 42:1997;113-119.
21. de Feyter P.J., Kay P., Disco C., Serruys P.W. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation. 100:1999;1777-1783.
22. de Jaegere P., Mudra H., Figulla H., et al. Intravascular ultrasound-guided optimized stent deployment Immediate and 6-months clinical and angiographic results from the Multicenter Ultrasound Stenting In Coronaries (music) study. Eur Heart J. 19:1998;1214-1223.
23. Fitzgerald P.J., Oshima A., Hayase M., et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 102:2000;523-530.
24. Albiero R., Rau T., Schluter M., et al. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation. 96:1997;2997-3005.
25. Colombo A., Hall P., Nakamura S., et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 91:1995;1676-1688.
26. REStenosis after IVUS-guided STenting (RESIST) Study Group, Schiele F., Meneveau N., Vuillemenot A., et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate A multicenter, randomized study comparing two strategies - with and without intravascular ultrasound guidance. J Am Coll Cardiol. 32:1998;320-328.
27. Schiele F., Meneveau N., Seronde M.F., et al. Medical costs of intravascular ultrasound optimization of stent deployment Results of the Multicenter Randomized Restenosis After Intravascular Ultrasound Stenting (resist) study. Int J Cardiovasc Intervent. 3:2000;207-213.
28. Russo R.J., Attubato M.J., Davidson C.J., et al. Angiography versus intravascular ultrasound-directed stent placement Final results from AVID. (abstr) Circulation. 100:(Suppl I):1999;I234.
29. Mudra H., di Mario C., de Jaegere P., et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS study). Circulation. 104:2001;1343-1349.
30. Oemrawsingh P.V., Mintz G.S., Schalij M.J., Zwinderman A.H., Jukema J.W., van der Wall E.E. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses Final results of a randomized comparison with angiographic guidance (TULIP study). Circulation. 107:2003;62-67.
31. Nicosia A., van der Giessen W.J., Airiian S.G., von Birgelen C., de Feyter P.J., Serruys P.W. Is intravascular ultrasound after coronary stenting a safe procedure? Three cases of stent damage attributable to ICUS in a tantalum coil stent. Cathet Cardiovasc Diagn. 40:1997;265-270.
32. Hausmann D., Erbel R., Alibelli-Chemarin M.J., et al. The safety of intracoronary ultrasound A multicenter survey of 2,207 examinations. Circulation. 91:1995;623-630.
33. Popma J.J., Kuntz R.E., Baim D.S. A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. Circulation. 106:2002;1592-1594.
34. De Bruyne B., Bartunek J., Sys S.U., Heyndrickx G. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation. 92:1995;3183-3193.
35. Pijls N.H., De Bruyne B., Peels K.H., et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med. 334:1996;1703-1708.
36. Bartunek J., Marwick T.H., Rodrigues A.C.T., et al. Dobutamine-induced wall motion abnormalities Correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol. 27:1996;1429-1436.
37. Chamuleau S.A.J., Meuwissen M., van Eck-Smit B.L.F., et al. Fractional flow reserve Absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease. J Am Coll Cardiol. 37:2001;1316-1322.
38. Hanekamp C.E.E., Koolen J.J., Pijls N.H., Michels H.R., Bonnier H.J. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 99:1999;1015-1021.
39. Fearon W.F., Luna J., Samady H., et al. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation. 104:2001;1917-1922.
40. Bech G.J., Pijls N.H., de Bruyne B., et al. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation. 99:1999;883-888.
41. Pijls N.H., Klauss V., Siebert U., et al. Coronary pressure measurement after stenting predicts adverse events at follow-up A multicenter registry. Circulation. 105:2002;2950-2954.
42. Sousa J.E., Serruys P.W., Costa M.A. New frontiers in cardiology. Drug-eluting stents Part II. Circulation. 107:2003;2383-2389.
43. Shah V.M., Mintz G.S., Apple S., Weissman N.J. Background incidence of late malapposition after bare-metal stent implantation. Circulation. 106:2002;1753-1755.
44. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 106:2002;798-803.
45. U.S. Food and Drug Administration. Cordis Corporation issues a health care professional letter regarding the CYPHER stent. FDA News: July 8, 2003. Available at: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00919.html. Accessed December 8, 2003.
46. Hong M.K., Mintz G.S., Lee C.W., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries A serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (aspect). Circulation. 107:2003;517-520.
47. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 107:2003;24-27.
48. Lemos P.A., Lee C.H., Degertekin M., et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes Insights from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol. 41:2003;2093-2099.
49. King S.B. Restenosis The mouse that roared. Circulation. 108:2003;248-249.
50. Lemos P.A., Saia F., Lighart J.M.R., et al. Coronary restenosis after sirolimus-eluting stent implantation Morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 108:2003;257-260.
51. Nissen S.E., Yock P. Intravascular ultrasound Novel pathophysiological insights and current clinical applications. Circulation. 103:2001;604-616.
52. Bech G.J., Droste H., Pijls N.H., et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart. 86:2001;547-552.
53. Mehra M.R., Ventura H.O., Stapleton D.D. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant. 14:1995;632-639.
54. Mintz G.S., Popma J.J., Pichard A.D., et al. Limitations of angiography in the assessment of plaque distribution in coronary artery disease A systematic study of target lesion eccentricity in 1,446 lesions. Circulation. 93:1996;924-931.
55. Kovach J.A., Mintz G.S., Pichard A.D., et al. Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty. J Am Coll Cardiol. 22:1993;1024-1032.
56. Matar F.A., Mintz G.S., Pinnow E., et al. Multivariate predictors of intravascular ultrasound end points after directional coronary atherectomy. J Am Coll Cardiol. 25:1995;318-324.
57. Tsuchikane E., Sumitsuji S., Awata N., et al. Final results of the STent versus directional coronary Atherectomy Randomized Trial (START). J Am Coll Cardiol. 34:1999;1050-1057.
58. Nishimura R.A., Edwards W.D., Warnes C.A., et al. Intravascular ultrasound imaging In vitro validation and pathologic correlation. J Am Coll Cardiol. 16:1990;145-154.
59. MacNeill B.D., Lowe H.C., Takano M., Fuster V., Jang I.K. Intravascular modalities for detection of vulnerable plaque Current status. Arterioscler Thromb Vasc Biol. 23:2003;1333-1342.